Pravastatin sodium/Fenofibrate

普伐他汀钠/非诺贝特

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePravastatin sodium/Fenofibrate
Drug Alias Name非诺贝特/普伐他汀钠Fenofibrate/Pravastatin sodiumFenofibrate - pravastatin mixtPravafenix
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator activated receptor agonistsHMG-CoA reductase inhibitors
TargetsPeroxisome proliferator activated receptorHMG-CoA reductase
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsDyslipidemias
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2011/04/14
Country/TerritoryEU
CombinationsYes Pravastatin sodiumFenofibrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Smb Sa
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Smb Sa
Inactive CompaniesN/A
Active IndicationsDyslipidemias
Inactive IndicationsN/A

Other Information

ATC CodeC10BA03
Related LinksKEGG